FIELD: pharmaceuticals.
SUBSTANCE: invention relates to pharmaceutical preparation and drug for topical administration useful in treatment of allergic and/or vasomotor rhinitis, respectively vasomotor conjunctivitis. Claimed preparation contains 50-500 mug of azelastine, 100-2000 mug of, such as leukotrien D4 antagonist (e.g., montelucast, zafirlucast, or pranlucast) or 5-lypoxigenase inhibitor (e.g., zyleuton, pipipost or AWD 23-115) and conventional pharmaceutically acceptable carriers. Method for production of abovementioned preparation also is disclosed.
EFFECT: pharmaceutical preparation and drug having accelerated and prolonged therapeutic effect and improved therapeutic efficiency due to synergic action of disclosed composition.
11 cl, 3 ex, 2 tbl
Authors
Dates
2007-01-27—Published
2001-02-05—Filed